Patent ID: 7939561

Claim:
A method of packaging a rapidly bioavailable diclofenac dosage form demonstrated to have a mean time to maximum plasma concentration (t max ) of from about 5 to about 40 minutes to discourage its administration in the treatment of chronic pain comprising: a) formulating diclofenac or a pharmaceutically acceptable salt thereof in a rapidly bioavailable tablet dosage form comprising an excipient base; and b) packaging said drug in a blister package divided into from five to fourteen medication segments, wherein: i) each medication segment corresponds to one day of treatment, ii) each medication segment is divided into from one to four unit doses corresponding to a daily dosage for said drug, and iii) said blister package is imprinted with indicia that distinguishes between said medication segments and instructs on the proper treatment with said drug; wherein said dosage form comprises from alkali metal carbonate or bicarbonate at a weight ratio to said diclofenac of from about 1:5 to about 4:5.